UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

Clinical cancer research, 2011-09, Vol.17 (18), p.5913-5925

2011

Volltextzugriff (PDF)

Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment

Journal of clinical oncology, 2020-11, Vol.38 (32), p.3740-3742

2020

Volltextzugriff (PDF)

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

PloS one, 2012-01, Vol.7 (1), p.e30062-e30062

2012

Volltextzugriff (PDF)

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

Cancer research (Chicago, Ill.), 2008-06, Vol.68 (11), p.4447-4454

2008

Volltextzugriff (PDF)

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Clinical cancer research, 2008-10, Vol.14 (19), p.6302-6309

2008

Volltextzugriff (PDF)

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Clinical cancer research, 2021-07, Vol.27 (13), p.3610-3619

2021

Volltextzugriff (PDF)

Minireview: SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression

Endocrinology (Philadelphia), 2014-11, Vol.155 (11), p.4124-4132

2014

Volltextzugriff (PDF)

Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

Cancer epidemiology, biomarkers & prevention, 2011-04, Vol.20 (4), p.619-627

2011

Volltextzugriff (PDF)

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

PloS one, 2020-09, Vol.15 (9), p.e0239686-e0239686

2020

Volltextzugriff (PDF)

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer

Clinical cancer research, 2017-08, Vol.23 (16), p.4592-4601

2017

Volltextzugriff (PDF)

Survival in Patients With De Novo Metastatic Prostate Cancer

JAMA network open, 2024-03, Vol.7 (3), p.e241970

2024

Volltextzugriff (PDF)

External Beam Radiation Therapy and Abiraterone in Men With Localized Prostate Cancer: Safety and Effect on Tissue Androgens

International journal of radiation oncology, biology, physics, 2015-06, Vol.92 (2), p.236-243

2015

Volltextzugriff (PDF)

MEK4 Function, Genistein Treatment, and Invasion of Human Prostate Cancer Cells

JNCI : Journal of the National Cancer Institute, 2009-08, Vol.101 (16), p.1141-1155

2009

Volltextzugriff (PDF)

Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy

Prostate cancer and prostatic diseases, 2019-12, Vol.22 (4), p.560-568

2019

Volltextzugriff (PDF)

Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors

Clinical cancer research, 2006-10, Vol.12 (20), p.6153-6160

2006

Volltextzugriff (PDF)

An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer

Clinical cancer research, 2007-11, Vol.13 (21), p.6429-6439

2007

Volltextzugriff (PDF)

Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer

Medical oncology (Northwood, London, England), 2016-07, Vol.33 (7), p.77-77, Article 77

2016

Volltextzugriff (PDF)

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis

PloS one, 2014-10, Vol.9 (10), p.e111545

2014

Volltextzugriff (PDF)

Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey

Cancer epidemiology, biomarkers & prevention, 2007-08, Vol.16 (8), p.1587-1594

2007

Volltextzugriff (PDF)

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

Clinical cancer research, 2021-11, Vol.27 (21), p.6001-6011

2021

Volltextzugriff (PDF)

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

European urology, 2020-05, Vol.77 (5), p.563-572

2020

Volltextzugriff (PDF)

Clinical determinants for successful circulating tumor DNA analysis in prostate cancer

The Prostate, 2019-05, Vol.79 (7), p.701-708

2019

Volltextzugriff (PDF)

CDK12 -Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade

JCO precision oncology, 2020-04 (4), p.382-392

2020

Volltextzugriff (PDF)

Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer

Clinical genitourinary cancer, 2024-06, Vol.22 (3), p.102100-102100, Article 102100

2024

Volltextzugriff (PDF)

1 – 25 von 294

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(272)
Mit Volltextzugriff
(240)

Publikationsform

2 weitere anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Resistance to CYP17A1 Inhibition with Abiraterone in Castration-Resistant Prostate Cancer: Induction of Steroidogenesis and Androgen Receptor Splice Variants

Two Steps Forward and One Step Back for Precision in Prostate Cancer Treatment

Impact of circulating cholesterol levels on growth and intratumoral androgen concentration of prostate tumors

Maintenance of intratumoral androgens in metastatic prostate cancer: a mechanism for castration-resistant tumor growth

Circulating Tumor Cells Predict Survival Benefit from Treatment in Metastatic Castration-Resistant Prostate Cancer

Phase II Multicenter Study of Enzalutamide in Metastatic Castration-Resistant Prostate Cancer to Identify Mechanisms Driving Resistance

Minireview: SLCO and ABC Transporters: A Role for Steroid Transport in Prostate Cancer Progression

Expression of SLCO Transport Genes in Castration-Resistant Prostate Cancer and Impact of Genetic Variation in SLCO1B3 and SLCO2B1 on Prostate Cancer Outcomes

Impact of mutations in homologous recombination repair genes on treatment outcomes for metastatic castration resistant prostate cancer

Association of Tissue Abiraterone Levels and SLCO Genotype with Intraprostatic Steroids and Pathologic Response in Men with High-Risk Localized Prostate Cancer

Survival in Patients With De Novo Metastatic Prostate Cancer

External Beam Radiation Therapy and Abiraterone in Men With Localized Prostate Cancer: Safety and Effect on Tissue Androgens

MEK4 Function, Genistein Treatment, and Invasion of Human Prostate Cancer Cells

Association of prostate cancer SLCO gene expression with Gleason grade and alterations following androgen deprivation therapy

Combined In vivo Effect of A12, a Type 1 Insulin-Like Growth Factor Receptor Antibody, and Docetaxel against Prostate Cancer Tumors

An Antibody Targeting the Type I Insulin-like Growth Factor Receptor Enhances the Castration-Induced Response in Androgen-Dependent Prostate Cancer

Docetaxel-related toxicity in metastatic hormone-sensitive and metastatic castration-resistant prostate cancer

Prostate cancer characteristics associated with response to pre-receptor targeting of the androgen axis

Do Statins Affect Androgen Levels in Men? Results from the Boston Area Community Health Survey

Circulating and Intratumoral Adrenal Androgens Correlate with Response to Abiraterone in Men with Castration-Resistant Prostate Cancer

Nucleosome Patterns in Circulating Tumor DNA Reveal Transcriptional Regulation of Advanced Prostate Cancer Phenotypes

Veterans Affairs Cooperative Studies Program Study #553: Chemotherapy After Prostatectomy for High-risk Prostate Carcinoma: A Phase III Randomized Study

Clinical determinants for successful circulating tumor DNA analysis in prostate cancer

CDK12 -Mutated Prostate Cancer: Clinical Outcomes With Standard Therapies and Immune Checkpoint Blockade

Adjuvant Chemotherapy and Survival After Radical Cystectomy in Histologic Subtype Bladder Cancer

Suchergebnisse filtern